EA200500800A1 - QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS - Google Patents
QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTSInfo
- Publication number
- EA200500800A1 EA200500800A1 EA200500800A EA200500800A EA200500800A1 EA 200500800 A1 EA200500800 A1 EA 200500800A1 EA 200500800 A EA200500800 A EA 200500800A EA 200500800 A EA200500800 A EA 200500800A EA 200500800 A1 EA200500800 A1 EA 200500800A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- het
- alkyloxy
- hydroxy
- alkyl
- hydrogen
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к применению соединения для изготовления лекарственного средства для лечения бактериальной инфекции, где указанное соединение является соединением формулыего фармацевтически приемлемой кислотно- или основно-аддитивной солью, его стереохимически изомерной формой или его N-оксидной формой, где Rпредставляет собой водород, галоген, полигалоСалкил, Cалкил, Ar или Het; p представляет собой целое число, равное 1 или 2; Rпредставляет собой Cалкилокси, СалкилоксиСалкилокси или Cалкилтио; Rпредставляет собой Ar, Het или Het; Rи Rпредставляют собой, каждый независимо, водород, Cалкил или бензил; или Rи Rвместе с атомом N, к которому они присоединены, могут образовывать радикал, выбранный из группы пирролидинила, 2-пирролинила, 3-пирролинила, пирролила, имидазолидинила, пиразолидинила, 2-имидазолинила, 2-пиразолинила, имидазолила, пиразолила, триазолила, пиперидинила, пиридинила, пиперазинила, пиридазинила, пиримидинила, пиразинила, триазинила, морфолинила и тиоморфолинила, каждое из указанных колец может быть, необязательно, замещено Cалкилом, галогеном, полигалоСалкилом, гидрокси, гидроксиСалкилом, Cалкилокси, амино, моно- или ди(Cалкил)амино, Cалкилтио, СалкилоксиСалкилом, СалкилтиоСалкилом или пиримидинилом; Rпредставляет собой водород, галоген, полигалоСалкил, Cалкил, Cалкилокси, Cалкилтио или два вицинальных радикала Rмогут быть взяты вместе с образованием двухвалентного радикала формулы -СН=СН-СН=СН-; r представляет собой целое число, равное 1 или 2; Rпредставляет собой водород, Cалкил, Ar, Het или Het; при условии, что бактериальная инфекция является другой, чем микобактериальная инфекция.The present invention relates to the use of a compound for the manufacture of a medicament for the treatment of a bacterial infection, where said compound is a compound of the pharmaceutically acceptable acid or base addition salt, its stereochemically isomeric form or its N-oxide form, where R is hydrogen, halogen, polyhaloalkyl C1-6 alkyl, Ar or Het; p is an integer equal to 1 or 2; R 1 is C 1-6 alkyloxy, C 1-6 alkyloxy C 1-6 alkyloxy or C 1-6 alkylthio; R4 is Ar, Het or Het; R1 and R4 are each independently hydrogen, C1-6 alkyl or benzyl; or R together with the atoms N, to which they are attached may form a radical selected from the group of pyrrolidinyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrrolyl, imidazolidinyl, pyrazolidinyl, 2-imidazolinyl, 2-pyrazolinyl, imidazolyl, pyrazolyl, triazolyl, piperidinyl , pyridinyl, piperazinyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, morpholinyl and thiomorpholinyl, each of these rings can be optionally substituted by C1-6alkyl, halogen, polyhaloxy4alkyl, hydroxy, hydroxy C1-6alkyloxy, amino, monocyan or polyacetate, polyhydroxyalkyl, hydroxy, hydroxy C1-6 l) amino, alkylthio, SalkiloksiSalkilom, SalkiltioSalkilom or pyrimidinyl; R 1 is hydrogen, halogen, polyhaloalkyl, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio or two vicinal radicals R3 can be taken together to form a bivalent radical of the formula -CH = CH-CH = CH-; r is an integer equal to 1 or 2; R4 is hydrogen, C1-6 alkyl, Ar, Het or Het; provided that the bacterial infection is other than mycobacterial infection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200500800A EA010601B1 (en) | 2005-06-09 | 2005-06-09 | Quinoline derivatives as antibacterial agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200500800A EA010601B1 (en) | 2005-06-09 | 2005-06-09 | Quinoline derivatives as antibacterial agents |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200500800A1 true EA200500800A1 (en) | 2006-12-29 |
EA010601B1 EA010601B1 (en) | 2008-10-30 |
Family
ID=40851968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200500800A EA010601B1 (en) | 2005-06-09 | 2005-06-09 | Quinoline derivatives as antibacterial agents |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA010601B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EG20543A (en) * | 1992-10-30 | 1999-07-31 | Procter & Gamble | Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones |
US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
CA2318842A1 (en) * | 1998-01-26 | 1999-07-29 | Julie Dorothy Warrack | Quinoline derivatives as antibacterials |
EP1527050B1 (en) * | 2002-07-25 | 2010-04-07 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
-
2005
- 2005-06-09 EA EA200500800A patent/EA010601B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA010601B1 (en) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO2977B1 (en) | Quinoline derivatives as antibacterial agents | |
CR20210001A (en) | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases | |
EA200800501A1 (en) | QUINOLINE DERIVATIVES AS ANTIBACTERIAL MEANS | |
NO20090580L (en) | Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors | |
BRPI0510560A (en) | substituted pyrido [2,3-d] pyrimidin-7-ones and their derivatives as therapeutic agents | |
EP3693369A3 (en) | Bromodomain inhibitors | |
NO20090581L (en) | Hydroxylated and methoxylated cyclopenta [D] pyrimidines as AKT protein kinase inhibitors | |
MX2010004491A (en) | Pyridine and pyrazine derivatives - 083. | |
NO20081026L (en) | Quinoline derivatives as antibacterial agents | |
CY1112247T1 (en) | KINOLIN PRODUCTS FOR THE THERAPEUTIC TREATMENT OF TREATMENT | |
TW200630374A (en) | Thiazolyldihydroindazoles | |
TW200801018A (en) | 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors | |
WO2022038365A3 (en) | Fumarate derivatives and their medical use | |
NO20081068L (en) | Quinoline derivatives as antibacterial agents | |
ME01484B (en) | Quinoline derivatives as antibacterial agents | |
TW200635592A (en) | Pyridyl-substituted spiro-hydantoin compounds and use thereof | |
NO20080481L (en) | Quinoline derivatives as antibacterial agents | |
MX2019004375A (en) | Bromodomain inhibitors. | |
EA200500800A1 (en) | QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS | |
TW200716109A (en) | Quinoline derivatives as antibacterial agents | |
MY163500A (en) | Quinoline derivatives as antibacterial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |